Showing 1 - 10 of 52
Good health is a crucial part of well-being but spending on health can be justified on economic grounds. The goal of reducing poverty provides a different but equally powerful case for health investments. However, if policymakers are to accelerate the substantial health gains of recent decades,...
Persistent link: https://www.econbiz.de/10005556956
The discussion about health care systems focuses on the dynamics of expenditures and on the weak growth of revenues. In this discussion it is widely overseen that medical expenditures and the supply of medical services depend crucially on the compensation of physician services. The paper...
Persistent link: https://www.econbiz.de/10005413013
The diffusion of health care technology is influenced by both the total market share of managed care organizations as well as the level of competition among them. This paper differentiates between HMO penetration and competition and examines their relationship to the adoption of cardiac...
Persistent link: https://www.econbiz.de/10005007503
GOOD HEALTH IS A CRUCIAL PART OF WELL-BEING BUT SPENDING ON HEALTH CAN BE JUSTIFIED ON ECONOMIC GROUNDS. THE GOAL OF REDUCING POVERTY PROVIDES A DIFFERENT BUT EQUALLY POWERFUL CASE FOR HEALTH INVESTMENTS. HOWEVER, IF POLICYMAKERS ARE TO ACCELERATE THE SUBSTANTIAL HEALTH GAINS OF RECENT DECADES,...
Persistent link: https://www.econbiz.de/10005408428
We set up an open-economy, three-country version of the endogenous- mortality model of Lagerloef (forthcoming in the … International Economic Review). The model is calibrated to pre-industrial mortality data from England, France and Sweden. Fitting … parameters to match observed rates of correlation in mortality rates, the model can also account for: (1) differences in the …
Persistent link: https://www.econbiz.de/10005412676
Although a number of studies have been conducted on health production functions, little attention has been given to pharmaceuticals as a separate input into the production of health. Building upon existing published work, this paper uses an alternative specification and more recent data to...
Persistent link: https://www.econbiz.de/10005413009
The health care industry is being transformed. Large firms are merging and acquiring other firms. Alliances and contractual relations between players in this market are shifting rapidly. Within the next few years, many markets are predicted to be dominated by a few large firms. Antitrust...
Persistent link: https://www.econbiz.de/10005413015
The incentive contracts that managed care organizations write with physicians have generated considerable controversy. Critics fear that if informational asymmetries inhibit patients from directly assessing the quality of care provided by their physician, competition will lead to a "race to the...
Persistent link: https://www.econbiz.de/10005413291
In this paper we provide a Random-Utility based derivation of the Dirichlet-Multinomial regression and posit it as a convenient alternative for dealing with overdispersed multinomial data. We show that this model is a natural extension of McFadden's conditional logit for grouped data and show...
Persistent link: https://www.econbiz.de/10005119073
This paper examines how demand for prescription drugs is influenced by different types of insurance. In order to understand demand characteristics and the competitiveness of pharmaceutical markets, both intermolecular (therapeutic) and intramolecular (generic) substitutions are studied in the...
Persistent link: https://www.econbiz.de/10005561530